Hydration support
How Retatrutide works Retatrutide is designed to activate three receptor systems involved in metabolic control: GLP-1 receptor activity GLP-1 signalling is associated with appetite reduction, delayed gastric emptying and glucose-dependent insulin support
Comorbidities included hypertensive diseases (I10-I16), Type 2 diabetes mellitus (E11), chronic lower respiratory diseases (J40-J47), neoplasms (C00-D49), psychoactive substance use (F10-F19), ischemic heart diseases (I20-I25), chronic kidney disease (N18), and cerebrovascular diseases (I60-I69)
BPC-157 (10mg) $39.00 BPC-157 is a synthetic pentadecapeptide derived from the gastric body protection compound, studied for angiogenic activity, nitric oxide pathway modulation, and tissue repair signaling
Weeks 14: 0.25 mg once weekly Weeks 58: 0.5 mg once weekly Weeks 912: 1 mg once weekly (if tolerated) Weeks 1316: 1.5 mg once weekly (if needed) Week 17+: Up to 2 mg once weekly (maintenance) Monitoring Plan Week 2: Check for GI symptoms Week 4: Assess weight and glucose Week 8: Review need for dose increase Ongoing: Monitor A1C (if diabetic), kidney function, blood pressure How to reconstitute Semaglutide and Calculate Dosing Use our easy-to-follow Semaglutide Calculator to determine your personalized dosing schedule
